Provided by Tiger Fintech (Singapore) Pte. Ltd.

Portage Biotech Inc.

10.27
-0.4900-4.55%
Post-market: 10.15-0.1200-1.17%19:54 EDT
Volume:124.02K
Turnover:1.28M
Market Cap:16.90M
PE:-0.16
High:10.94
Open:10.72
Low:9.81
Close:10.76
Loading ...

BRIEF-Portage Biotech Re-Launches Adenosine Unit As Independently Managed Co

Reuters
·
06 Jan

Portage Biotech: Re-Launches Adenosine Unit as Independently Managed Co

THOMSON REUTERS
·
06 Jan

Portage Biotech: Peter Molloy Has Been Appointed CEO of Unit, to Be Named Cyncado Therapeutics, Inc

THOMSON REUTERS
·
06 Jan

Portage announces relaunch of adenosine subsidiary as independently managed

TIPRANKS
·
06 Jan

Press Release: Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company

Dow Jones
·
06 Jan

Portage Biotech trading resumes

TIPRANKS
·
24 Dec 2024

Portage Biotech trading halted, volatility trading pause

TIPRANKS
·
24 Dec 2024

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Benzinga
·
18 Dec 2024

Top Midday Gainers

MT Newswires Live
·
18 Dec 2024

Crude Oil Down Over 1%; US Industrial Production Declines In November

Benzinga
·
18 Dec 2024

Portage Biotech Shares Double on Letter of Intent to Sell Subsidiary

Dow Jones
·
17 Dec 2024

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday

MT Newswires Live
·
17 Dec 2024

BUZZ-Portage Biotech soars on potential deal with Immunova

Reuters
·
17 Dec 2024

Portage Biotech Shares Soar Over 212% in Premarket Activity After Announcing Entering Letter of Intent With Immunova

MT Newswires Live
·
17 Dec 2024

BRIEF-Portage Biotech Announces Letter Of Intent With Immunova For An Option To Acquire Iox Therapeutics

Reuters
·
17 Dec 2024

Portage Biotech enters letter of intent with Immunova for option to acquire iOx

TIPRANKS
·
17 Dec 2024

Portage Biotech Inc - Have Agreed With Immunova to Negotiate Acquisition of Iox Therapeutics

THOMSON REUTERS
·
17 Dec 2024

Portage Biotech Announces Letter of Intent With Immunova for an Option to Acquire Iox Therapeutics, Ltd

THOMSON REUTERS
·
17 Dec 2024

Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd

GlobeNewswire
·
17 Dec 2024

Portage Biotech Inc. Appoints New CEO Amid Leadership Change

TIPRANKS
·
14 Dec 2024